Was somnolence reported as an adverse reaction in patients with muscle spasm?

0
Posted

Was somnolence reported as an adverse reaction in patients with muscle spasm?

0

In the two, 14-day clinical efficacy trials, somnolence was reported as an adverse reaction in 1% of patients on AMRIX 15-mg and in 2% of patients on AMRIX 30-mg. In the clinical trials, less than 2% of patients discontinued therapy due to somnolence.

Related Questions